News | September 27, 2023
Hermes Pharma to invest €25 million to bolster manufacturing capabilities
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Good momentum in commercial CDMO business
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
UTD2 is the world's first oral epothilone microtubule inhibitor
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Subscribe To Our Newsletter & Stay Updated
